Our results are in line with those previously reported in septic critically ill patients regarding both cTnT and cTnI levels [40,41,42,43], suggesting that cTnT levels may add to risk stratification and in a better manner than inflammatory or thrombotic markers in COVID-19 patients [9,16,17,18,19]. The gene discussed is TNNT2; the disease is COVID-19.